Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
The abundance and diversity of the gut microbiota have been shown to change in individuals with metabolic disorders (1)
XXX - Xylooligosaccharides (XOS) vs Placebo & Pre-Diabetic Condition is a randomized prevention trial studying 2.8 g/day Xylooligosaccharides (XOS) or placebo in 34 adult subjects with Pre-Diabetic Condition (1)
Gut microbiota characterization in feces, oral glucose tolerance test (OGTT) (1).
Xylooligosaccharides (XOS) induced notable changes in microbial diversity that were similar in both healthy and prediabetic subjects, although the changes varied dep…